Int. J. Mol. Sci. 2007, 8(7), 714-722; doi:10.3390/i8070714
Article

3D-QSAR Study of Potent Inhibitors of Phosphodiesterase-4 Using a CoMFA Approach

College of Pharmacy, Jinan University, Guangzhou, P.R. of China
* Author to whom correspondence should be addressed.
Received: 5 June 2007; in revised form: 13 July 2007 / Accepted: 19 July 2007 / Published: 24 July 2007
PDF Full-text Download PDF Full-Text [194 KB, uploaded 20 June 2008 16:51 CEST]
Abstract: Phosphodiesterase-4 (PDE4) plays an important role in treatment of asthma andchronic obstructive pulmonary disease. Thirty-one analogs displaying variable inhibition ofPDE4 were selected to develop models for establishing three-dimensional quantitativestructure-activity relationships (3D-QSAR). Comparative molecular field analysis(CoMFA) was conducted on the group of analogs to determine the structural requirementsfor potency in inhibiting PDE4. The resulting model exhibited good q2 and r2 values up to0.741 and 0.954 for CoMFA. The contributions from the steric and electrostatic fields were0.915 and 0.085 respectively. The 3D-QSAR model should be very useful for design ofnovel PDE 4 inhibitors.
Keywords: QSAR; CoMFA; Phosphodiesterase-4

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Yang, Z.; Sun, P. 3D-QSAR Study of Potent Inhibitors of Phosphodiesterase-4 Using a CoMFA Approach. Int. J. Mol. Sci. 2007, 8, 714-722.

AMA Style

Yang Z, Sun P. 3D-QSAR Study of Potent Inhibitors of Phosphodiesterase-4 Using a CoMFA Approach. International Journal of Molecular Sciences. 2007; 8(7):714-722.

Chicago/Turabian Style

Yang, Zhaoqi; Sun, Pinghua. 2007. "3D-QSAR Study of Potent Inhibitors of Phosphodiesterase-4 Using a CoMFA Approach." Int. J. Mol. Sci. 8, no. 7: 714-722.

Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert